pharmaphorum

JANUARY 5, 2023

The company develops mRNA therapeutics and vaccines , and the move will enable it to utilise the synthetic biology and enzyme tech of 2018-founded Japanese company OriCiro, which develops cell-free DNA synthesis and amplification technologies, and thereby expand Moderna’s portfolio.

Gene Sequencing 97

Gene Sequencing DNA Vaccination Vaccine 97

Pharmaceutical Technology

MAY 24, 2023

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence.

Protein 130

Protein Antibody Medicine Development 130

XTalks

MARCH 21, 2022

Credited as a pioneering RNA interference (RNAi) therapeutics company, Alnylam Pharmaceuticals is taking Pfizer and Moderna to court, claiming that the companies’ use of the lipid nanoparticle (LNP)-based RNA delivery technology in their mRNA COVID-19 vaccines infringes on a patented technology. To date, Pfizer has garnered $36.7

RNA 98

RNA Vaccination Vaccine Sales 98

Drug Discovery World

SEPTEMBER 14, 2023

This broad multi-platform collaboration will leverage the scientific expertise and core operational capabilities of both companies, combining Immatics’ TCR platform with Moderna’s mRNA technology, and span various therapeutic modalities including bispecifics, cell therapy and cancer vaccines.

Development 52

Development Vaccination Vaccine In-Vivo 52

Pharmaceutical Technology

DECEMBER 9, 2022

Pharmaceutical Technology Excellence Rankings – The Verdict. The company is ranked in the M&A, PRODUCT LAUNCHES and RESEARCH AND DEVELOPMENT categories in the 2022 Pharmaceutical Technology Excellence Rankings. A deep understanding of science supports proven expertise in solid-state development.

Development 130

Development Manufacturing Production Vaccination 130

XTalks

MARCH 8, 2022

On International Women’s Day, Xtalks is celebrating women’s leadership in the life sciences by highlighting some of the female leaders at the forefront of scientific discovery, as well as the continuing challenges of attaining more equitable representation.

Life Science 105

Life Science Gene Therapy DNA Vaccination 105

Drug Discovery World

JANUARY 9, 2023

The agreement means cancer patients will get early access to trials exploring personalised mRNA therapies, like cancer vaccines. . Trials for innovative treatments could start as early as autumn 2023. . It is an important reminder that the Life Sciences Industry has the potential to be a key growth driver for the UK economy.” .

Research 52

Research Vaccination Vaccine Trials 52

Drug Discovery World

AUGUST 31, 2022

Biotechnology company Moderna has filed a patent infringement lawsuit against Pfizer and BioNTech in relation to the use of its messenger RNA (mRNA) technology and Pfizer and BioNTech’s Covid-19 Comirnaty vaccine. In particular, Moderna believes Pfizer and BioNTech copied two featured of its mRNA technologies.

Vaccination 52

Vaccination Vaccine Sales RNA 52

pharmaphorum

OCTOBER 12, 2022

David Del Bourgo (CEO and co-founder, Whitelab Genomics) has always been passionate about introducing disruptive, innovative technologies to markets. We founded Whitelab Genomics after realising the potential to use data, data science, and AI in a more systematic way to develop genomic therapies,” Del Bourgo says.

Genome 105

Genome Genomics Medicine Development 105

Pharmaceutical Technology

SEPTEMBER 15, 2022

As a result of huge global sales of mRNA Covid-19 vaccines, the split in profits between Pfizer and BioNTech’s Comirnaty contributed towards revenues of $81.3bn and $22.4bn last year, respectively. The post Top biopharmaceutical Covid-19 vaccine companies boosted with over 80% revenue growth appeared first on Pharmaceutical Technology.

Vaccination 272

Vaccination Vaccine Sales Generic Drugs 272

XTalks

DECEMBER 17, 2021

Xtalks is taking a look at some of the major stories and innovations of the year in the life sciences, many of which were driven by new, emerging and improved technologies. The year 2021 was all about continuing innovations in the life sciences. Life Science Innovations: Malaria and Influenza Vaccines.

Life Science 98

Life Science Vaccination Vaccine Trials 98

Pfizer

FEBRUARY 9, 2023

Pfizer and BioNTech Initiate Phase 1/2 Study of First mRNA-based Shingles Vaccine Program kimkevin Thu, 02/09/2023 - 15:05 Pfizer and BioNTech Initiate Phase 1/2 Study of First mRNA-based Shingles Vaccine Program Friday, February 10, 2023 - 06:45am Share Phase 1/2 trial will enroll up to 900 healthy U.S.

Vaccination 75

Vaccination Vaccine Clinical Trials Clinical Trials 75

Pharmaceutical Technology

AUGUST 1, 2022

Before the Covid-19 pandemic, government-led investment and engagement in life sciences was relatively restricted worldwide, with the industry mostly funded via private investment. As a result, multiple vaccines, including Pfizer /BioNTech’s mRNA vaccine, Comirnaty, were licensed for use within a year of development beginning.

Vaccination 234

Vaccination Vaccine Bacteria Life Science 234

pharmaphorum

AUGUST 26, 2022

Moderna has filed complaints in the US and Germany claiming that the mRNA technology used to make Pfizer and BioNTech’s Comirnaty vaccine infringes multiple patents that cover its own Spikevax shot. ” There’s no world yet on whether a counter-suit may be in the offing.

Vaccination 59

Vaccination Vaccine Sales Immune Response 59

pharmaphorum

JANUARY 12, 2022

If you had been told that within a few months, you’d be living in the middle of the biggest pandemic since the 1918 global flu outbreak, but that thanks to new mRNA technology, vaccine prototypes would be ready for trials within weeks and the first shots would go into arms before the end of 2020, what would you have thought?

Vaccination 52

Vaccination Vaccine Trials Marketing 52

pharmaphorum

AUGUST 5, 2022

Such inorganic growth is no longer viable, argues Pervaise Khan, Accenture’s UK Life Sciences Lead. The pace of innovation in biopharma has rocketed over the last two years, with vaccines, new antivirals, and therapies delivered at an unprecedented pace.

Life Science 52

Life Science Marketing Vaccination Vaccine 52

The Pharma Data

MAY 31, 2022

Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Takeda ( TSE:4502/NYSE:TAK ) announced to transfer the marketing authorization in Japan for Moderna’s COVID-19 vaccine Spikevax TM (mRNA-1273) from Takeda to Moderna in Japan as of August 1, 2022. Moderna, Inc., About Takeda.

Vaccination 52

Vaccination Vaccine Marketing RNA 52

Drug Discovery World

JANUARY 2, 2024

Cancer Research Horizon’s Innovation Summit 2023 took place on 21 November 2023 at the Royal Society of Medicine, and included talks from researchers translating their research, as well as networking with members of the entrepreneurial ecosystem. DDW’s Megan Thomas spoke to a range of attendees. BioNTech is also working in this space.

Research 59

Research Vaccination Vaccine Medicine 59

The Pharma Data

JULY 18, 2021

Food and Drug Administration (FDA) granted Priority Review designation for the Biologics License Application (BLA) for their mRNA vaccine to prevent COVID-19 in individuals 16 years of age and older. The Pfizer-BioNTech COVID-19 vaccine, which is based on BioNTech proprietary mRNA technology, was developed by both BioNTech and Pfizer.

Licensing 52

Licensing Licensing Vaccination Vaccine 52

Cloudbyz

MARCH 6, 2024

Unlike traditional small molecule drugs, which are chemically synthesized, biologics are produced through complex biotechnological processes, often involving recombinant DNA technology. This allows for the creation of highly specific and targeted therapies that can modulate biological pathways with remarkable precision.

Gene 73

Gene Immune Response Manufacturing Gene Therapy 73

The Pharma Data

AUGUST 5, 2021

Biopharmaceutical New Technologies is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. About Gilead Sciences. Gilead Sciences, Inc. All Kite employees at the Gaithersburg facility were offered employment with BioNTech prior to closing. About BioNTech.

Manufacturing 52

Manufacturing Vaccination Vaccine Development 52

The Pharma Data

OCTOBER 6, 2021

COMIRNATY, which is based on BioNTech’s proprietary mRNA technology, was developed by both BioNTech and Pfizer. At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. About Pfizer: Breakthroughs That Change Patients’ Lives. About BioNTech.

Vaccination 52

Vaccination Vaccine Antibody Medicine 52

pharmaphorum

NOVEMBER 1, 2022

In 2023 we will see the return of SAE’s RNA Therapeutics conference to a live in-person event, showcasing an update on mRNA therapeutic applications, coupled with an industry outlook of the field. Benefits of attending: Explore how mRNA leads the way in the genetic medicine space as the next generation of novel drug modalities.

RNA 52

RNA Genetics Gene Editing In-Vitro 52

The Pharma Data

JUNE 1, 2022

Annaliesa is a world-class scientist with a track record of delivering both vaccines and therapeutics in pioneering new areas of science and where there is urgent unmet need. She leaves Pfizer’s Vaccine R&D group stronger than ever and poised to continue to deliver innovative science.”.

Vaccination 40

Vaccination Vaccine Development Research 40

Drug Discovery World

OCTOBER 20, 2022

The initiative is expected to have impacts across all industries and innovations fields, from FinTech to HealthTech, InsurTech to RegTech. JETRO says: “Start-up ecosystems are ideal platforms for bringing together innovators to develop new technologies and solutions, as well as to establish next-generation companies across the country.

Development 52

Development Drugs Life Science Marketing 52

Drug Discovery World

NOVEMBER 24, 2022

With European life sciences R&D investment at a 20-year low, biopharmaceutical associations and MEPs are calling on the EU to modernise its policies. Fortunately, the EFPIA report also offers a detailed list of recommendations and the hope that with a proactive approach to nurturing life sciences, this trend can be reversed. .

Gene Therapy 98

Gene Therapy Gene Clinical Trials Clinical Trials 98

Cloudbyz

MAY 22, 2023

The Power of mRNA Vaccines One of the biggest revelations from the successful COVID-19 vaccine trials is the effectiveness of mRNA technology. The Pfizer-BioNTech and Moderna vaccines, which use this technology, have shown efficacy rates of around 95% and 94% respectively. Here’s how: 1.

Vaccination 52

Vaccination Vaccine Trials Development 52

The Pharma Data

MAY 27, 2022

Healthcare professionals can now use Vaxzevria as a third dose booster in patients previously given a primary vaccine schedule of either Vaxzevria or an EU-approved mRNA COVID-19 vaccine. This vaccine technology has been used by scientists over the past 40 years to fight other infectious diseases such as the flu, Ebola, and HIV.(14).

Vaccination 52

Vaccination Vaccine Immune Response Medicine 52

The Pharma Data

APRIL 15, 2022

The Pfizer-BioNTech COVID-19 Vaccine, which is based on BioNTech’s proprietary mRNA technology, was developed by both BioNTech and Pfizer. At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. About Pfizer: Breakthroughs That Change Patients’ Lives.

Immune Response 52

Immune Response Vaccination Vaccine Clinical Trials 52

pharmaphorum

JANUARY 12, 2022

Only a regulatory framework that “embraces a culture of excellence and innovation” will make Europe a world leader in life sciences and ensure people can reap the benefits of life-changing new treatments. Innovation and unmet need. The problem, though, is not a lack of innovation. Ensuring access.

Regulation 105

Regulation Medicine Marketing Gene Therapy 105

pharmaphorum

SEPTEMBER 22, 2022

Alexandre Le Vert, CEO and co-founder of Osivax, discusses the company’s breakthrough vaccine technology, oligoDOM, and how it’s driving the development of new influenza and SARS-CoV-2 vaccines that attack T-cells, providing a long-lasting effect. The technology. The virus can’t divide and so disappears.

Vaccination 97

Vaccination Vaccine Antibody Clinical Trials 97

BioSpace

NOVEMBER 20, 2022

Former Theranos CEO Elizabeth Holmes will serve 11 years in prison on four counts of fraud, according to her sentencing by a federal judge in a California courtroom on Friday afternoon.

Antibody 62

Antibody Medicine Research Clinical Trials 62

Drug Discovery World

DECEMBER 20, 2022

As 2022 draws to a close, life sciences market analysts attempt to correctly predict what the next 12 months might bring to the drug discovery sector. Novel therapeutic platforms will drive innovation . In summary, 2023 could be a very exciting year for life sciences.

Drugs 52

Drugs Gene Editing Clinical Trials Clinical Trials 52

pharmaphorum

APRIL 29, 2021

It will enable them understand the biology of the BBB, explore the latest technological innovations and develop more predictive preclinical models. Uncover current controversies and progress in human induced pluripotent stem cell derived brain endothelial cells and various approaches to driving innovation in models of the BBB.

Drug Delivery 52

Drug Delivery Gene Therapy In-Vivo Antibody 52

pharmaphorum

AUGUST 27, 2020

A world-class science and start-up ecosystem. The Biotechnology and Biological Sciences Research Council (BBSRC), part of UK Research and Innovation (UKRI), works with universities, research organisations, businesses, charities, and government to develop a supportive ecosystem. COVID-19 sparks change. About the author.

Vaccination 122

Vaccination Vaccine Life Science Clinical Trials 122

The Pharma Data

SEPTEMBER 8, 2020

Nasdaq: MRNA), Novavax, Inc. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. About BioNTech Biopharmaceutical New Technologies is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases.

Vaccination 52

Vaccination Vaccine Containment Clinical Trials 52

The Pharma Data

JUNE 17, 2022

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. About BioNTech.

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52